Literature DB >> 18214205

Norovirus GII.4 strains and outbreaks, Australia.

Elise T V Tu, Thanh Nguyen, Phoebe Lee, Rowena A Bull, Jennie Musto, Grant Hansman, Peter A White, William D Rawlinson, Christopher J McIver.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 18214205      PMCID: PMC2878217          DOI: 10.3201/eid1307.060999

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Viral gastroenteritis affects millions of people of all ages worldwide, and some seasonality has been observed in outbreak occurrences (–). During early 2006 in New South Wales (NSW), a marked increase in outbreaks of gastroenteritis occurred (Figure): 155 outbreaks were reported during the first 5 months compared with 88 outbreaks during 2005. During the first 5 months of 2006, the Enteric Pathogens Laboratory–South Eastern Area Laboratory Services (EPL-SEALS) recorded an increase in norovirus in stool samples, detected by using an enzyme immunoassay (IDEIA Norovirus, DakoCytomation, Cambridgeshire, UK). From January through May 2006, the proportion of samples positive for norovirus increased successively: 0/47 (0%), 1/73 (1.4%), 5/169 (3.0%), 8/106 (7.5%), and 93/413 (22.5%). This trend followed the increasing reports of outbreaks made to the NSW Department of Health (Figure). In May, the rate of norovirus detection (22.5%) was significantly greater than that of any other pathogen (Fisher exact test, p<0.0001), including intestinal parasites, foodborne bacterial pathogens (Salmonella, Shigella, and Camplylobacter), and enteric viruses (rotavirus, adenovirus, and astrovirus).
Figure

Number of outbreaks reported to the New South Wales Department of Health, January 2004–July 2006.

Number of outbreaks reported to the New South Wales Department of Health, January 2004–July 2006. In April 2006, the NSW Department of Health Public Health Real-time Emergency Department Surveillance System (PHREDSS) detected a significant increase in visits for gastroenteritis. This system records cases in real time for each visit to an emergency department from patient demographic information and syndromes diagnosed according to the International Classification of Diseases, version 9, Clinical Modification (ICD-9-CM) (). Information collected came from a population of >4 million persons, predominantly in the Greater Sydney metropolitan region. During April and May 2006, >8,000 visits for vomiting and diarrhea were recorded in PHREDSS, which is ≈3,000 above the average number of cases for this period for the previous 5 years. During this 8-week period, reports of clinically diagnosed outbreaks in institutional settings also increased; 129 outbreaks affected >3,485 persons. This number of outbreaks is the highest ever reported in the April–May (autumn) period for this region since data for outbreaks (mainly from aged-care facilities, hospitals, childcare centers, and schools) were collected by NSW Department of Health in 2004. Furthermore, laboratories detected norovirus in 37 (28.7%) of 129 outbreaks investigated by public health authorities. The stool samples examined by EPL-SEALS in May 2006 were from patients treated in public hospitals and nursing homes within the Eastern Sydney and Illawarra regions as well as referred samples from private laboratories serving the Greater Sydney region. Sequencing of a random selection of 15 positive samples representative of the diverse location of case-patients indicated that 10 (66.7%) of 15 were GII.4 genotype. The nucleotide sequence of 266 bp of the N terminus of the capsid gene closely resembled (98%) the sequence of Farmington Hills virus and was 100% identical over the same region to norovirus Rhyl440. The remaining positive strains belonged to GII.3 (4 of 15) and GII.12 (1 of 15). The latter strain, designated Schwerin virus, was previously isolated in outbreaks in Germany during 2000. Two of these sequenced samples were from nursing home outbreaks and typed as GII.3 and GII.4. The association with outbreaks of the remaining 13 sequenced samples is uncertain. Norovirus epidemics occurred throughout the world in 2002 () and 2004 () and were characterized by the large number of persons affected, multiple routes of transmission, and persistence of endemicity despite rigorous control efforts. In Australia from 1997 to 2000, a period of high activity occurred, dominated by the GII.4 epidemic strain designated U.S. 95/96 (). Farmington Hills virus was responsible for subsequent outbreaks in Sydney in 2002 and followed a decline in norovirus outbreaks during 2001. After the 2002 outbreaks in Australia, a period of low norovirus activity persisted before the 2004 emergence of another GII.4 variant, designated Hunter virus (), which predominated in outbreaks in nursing homes and hospitals. More than 400 outbreaks affecting >15,000 persons occurred in NSW during 2004 (). The Hunter virus was subsequently determined to be the etiologic agent in hundreds of outbreaks occurring in Holland (), New Zealand (Gail Greening, pers. comm.), Taiwan, and Japan. The occurrence of norovirus epidemics in the Australian autumn (March–May) contradicts the perception that the disease is strongly associated with the winter season, when the incidence of respiratory infections increases (). Indeed, other norovirus outbreaks have previously been reported in the summer season (,).The alternating trend of high and low incidence of outbreaks (Figure) may be related to several factors, some of which may have been implicated in these outbreaks. Such factors include development of herd immunity to the dominating strain, which is short-term; emergence of an epidemic strain with no herd immunity; increased genomic variation due to point mutation or recombination (); or other mechanisms.
  8 in total

1.  Cold weather seasonality of gastroenteritis associated with Norwalk-like viruses.

Authors:  A W Mounts; T Ando; M Koopmans; J S Bresee; J Noel; R I Glass
Journal:  J Infect Dis       Date:  2000-05       Impact factor: 5.226

2.  Norwalk-like virus 95/96-US strain is a major cause of gastroenteritis outbreaks in Australia.

Authors:  Peter A White; Grant S Hansman; Angelina Li; Joanne Dable; Monica Isaacs; Mark Ferson; Christopher J McIver; William D Rawlinson
Journal:  J Med Virol       Date:  2002-09       Impact factor: 2.327

3.  Outbreaks of acute gastroenteritis on cruise ships and on land: identification of a predominant circulating strain of norovirus--United States, 2002.

Authors:  Marc-Alain Widdowson; Elaine H Cramer; Leslie Hadley; Joseph S Bresee; R Suzanne Beard; Sandra N Bulens; Myrna Charles; Wairimu Chege; Elmira Isakbaeva; Jennifer G Wright; Eric Mintz; David Forney; Jeffrey Massey; Roger I Glass; Stephan S Monroe
Journal:  J Infect Dis       Date:  2004-06-08       Impact factor: 5.226

4.  Characteristics of Norovirus outbreaks during a non-epidemic season.

Authors:  Tatsuya Miyoshi; Kiyoko Uchino; Mitsuko Matsuo; Yoshiharu Ikeda; Hisayoshi Yoshida; Hisako Sibata; Fumitoshi Fujii; Tomoyuki Tanaka
Journal:  Jpn J Infect Dis       Date:  2006-04       Impact factor: 1.362

5.  Emergence of a new norovirus genotype II.4 variant associated with global outbreaks of gastroenteritis.

Authors:  Rowena A Bull; Elise T V Tu; Christopher J McIver; William D Rawlinson; Peter A White
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

6.  Norovirus recombination in ORF1/ORF2 overlap.

Authors:  Rowena A Bull; Grant S Hansman; Leighton E Clancy; Mark M Tanaka; William D Rawlinson; Peter A White
Journal:  Emerg Infect Dis       Date:  2005-07       Impact factor: 6.883

7.  An automated, broad-based, near real-time public health surveillance system using presentations to hospital Emergency Departments in New South Wales, Australia.

Authors:  David J Muscatello; Tim Churches; Jill Kaldor; Wei Zheng; Clayton Chiu; Patricia Correll; Louisa Jorm
Journal:  BMC Public Health       Date:  2005-12-22       Impact factor: 3.295

8.  A summertime peak of "winter vomiting disease": surveillance of noroviruses in England and Wales, 1995 to 2002.

Authors:  Ben A Lopman; Mark Reacher; Chris Gallimore; Goutam K Adak; Jim J Gray; David W G Brown
Journal:  BMC Public Health       Date:  2003-03-24       Impact factor: 3.295

  8 in total
  6 in total

Review 1.  Epidemiology, Clinical Features, and Unusual Complications of Norovirus Infection in Taiwan: What We Know after Rotavirus Vaccines.

Authors:  Meng-Che Lu; Sheng-Chieh Lin; Yi-Hsiang Hsu; Shih-Yen Chen
Journal:  Pathogens       Date:  2022-04-09

2.  Phylodynamic reconstruction reveals norovirus GII.4 epidemic expansions and their molecular determinants.

Authors:  J Joukje Siebenga; Philippe Lemey; Sergei L Kosakovsky Pond; Andrew Rambaut; Harry Vennema; Marion Koopmans
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

3.  Molecular epidemiology of norovirus gastroenteritis investigated using samples collected from children in Tunisia during a four-year period: detection of the norovirus variant GGII.4 Hunter as early as January 2003.

Authors:  Khira Sdiri-Loulizi; Katia Ambert-Balay; Hakima Gharbi-Khelifi; Nabil Sakly; Mouna Hassine; Slaheddine Chouchane; Mohamed Neji Guediche; Pierre Pothier; Mahjoub Aouni
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

4.  High incidence of norovirus GII.4 outbreaks in hospitals and nursing homes in Catalonia (Spain), 2010-2011.

Authors:  P Godoy; G Ferrrus; N Torner; N Camps; M R Sala; S Guix; R Bartolomé; A Martínez; M De Simón; A Domínguez
Journal:  Epidemiol Infect       Date:  2014-05-27       Impact factor: 4.434

5.  Molecular Evolution of the VP1 Gene in Human Norovirus GII.4 Variants in 1974-2015.

Authors:  Takumi Motoya; Koo Nagasawa; Yuki Matsushima; Noriko Nagata; Akihide Ryo; Tsuyoshi Sekizuka; Akifumi Yamashita; Makoto Kuroda; Yukio Morita; Yoshiyuki Suzuki; Nobuya Sasaki; Kazuhiko Katayama; Hirokazu Kimura
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640

6.  A Multi-Site Study of Norovirus Molecular Epidemiology in Australia and New Zealand, 2013-2014.

Authors:  Kun Lee Lim; Joanne Hewitt; Alefiya Sitabkhan; John-Sebastian Eden; Jennifer Lun; Avram Levy; Juan Merif; David Smith; William D Rawlinson; Peter A White
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.